The Chase Group proudly announces another successful leadership recruitment for Ionis Pharmaceuticals with the placement of the Executive Director of Drug Safety. Following our recent placement of the Vice President of Drug Safety, the latest addition to the Ionis Drug Safety leadership team was secured in just 56 days and completed during the busy holiday season. Ionis is the leading company in RNA-targeted drug discovery and development focused on developing drugs for patients who have the highest unmet medical needs, such as those patients with severe and rare diseases. Using proprietary anti-sense technology, Ionis has created a diverse pipeline of first-in-class or best-in-class drugs, with over a dozen drugs in mid- to late-stage development. For more information on how The Chase Group successfully identifies, recruits, and secures high-caliber talent in this competitive arena, contact Ken Allison at email@example.com.